Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Nutritional Biochemistry|October 23, 2023
Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunctionAnnette Brandt, Katja Csarmann, Angélica Hernández-Arriaga, et al.
European Journal of Clinical Investigation|September 30, 2024
A weekly 4-methylpyrazole treatment attenuates the development of non-obese metabolic dysfunction-associated steatotic liver disease (MASLD) in male mice: Role of JNKKatharina Burger, Finn Jung, Raphaela Staltner, et al.
Scientific Reports|May 2, 2019
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestineAnnette Brandt, Angélica Hernández-Arriaga, Richard Kehm, et al.
Dialogues in Clinical Neuroscience|April 28, 2006
The German Research Network on Schizophrenia--impact on the management of schizophreniaWolfgang Wölwer, Anja Baumann, Andreas Bechdolf, et al.
Scientific Reports|September 9, 2021
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver diseaseAnja Baumann, Anika Nier, Angélica Hernández-Arriaga, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 25, 2020
Aging-related liver degeneration is associated with increased bacterial endotoxin and lipopolysaccharide binding protein levelsCheng Jun Jin, Anja Baumann, Annette Brandt, et al.
International Journal of Medical Microbiology : IJMM|April 4, 2021
Microbiota profiling in aging-associated inflammation and liver degenerationAnja Baumann, Angélica Hernández-Arriaga, Annette Brandt, et al.
Pageof 5